Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 4, 1996, Pages 500-503

  Wong, G C ^a   Tan, P ^a   Goh, Y T ^a   Ng, H S ^a   Chong, R ^a   Lee, L H ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

aminotransaminases; hepatic encephalopathy; immunosuppression; reactivation; seroconversion

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; IMMUNE DEFICIENCY; MALE; SEROCONVERSION; VIRUS CARRIER; VIRUS REACTIVATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARRIER STATE; CHRONIC DISEASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DISEASE PROGRESSION; DOXORUBICIN; ETOPOSIDE; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMANS; LEUCOVORIN; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; VINCRISTINE;

EID: 0029810587     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lau J Y N, Lai C L, Lin H J, Lok A S F, Liang R H S, Wu P C, et al. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients Q J Med 1989; 270:911-7
2. Galbraith R M, Eddleston A L W F, Williams R, Zuckerman A J, Bagshawe K D Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet 1975;2:528-30
3. Flowers M A, Heathcote J, Wanless I R, Sherman M, Reynolds WJ, Cameron RG. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy. Ann Intern Med 1990; 112 381-2.
4. Lok A S F, Liang R H S, Chiu E K W, Wong K L, Chan T K, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy Gastroenterology 1991, 100:182-8.
5. Bird G L A, Smith H, Portmann B. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers Q J Med 1989; 270:895-902
6. Yoshiba M, Sekiyama K, Iwabuchi S, Takatori M, Tanaka Y, Uchikoshi T Recurrent fulminant hepatic failure in a HB carrier after intensive chemotherapy Dig Dis Sci 1993; 38:1751-5.
7. Soh L T, Ang P T, Sng J, Chua E J, Ong Y W Fulminant hepatic failure in non-Hodgkin's lymphoma patients treated with chemotherapy. Eur J Cancer 1992, 28A:1338-9
8. Editorial Chemotherapy and hepatitis B. Lancet 1989, 2:1136-7
9. Pinto P C, Hu E, Bernstein-Singer M, Pinter Brown L, Govindarayan S. Acute hepatic injury after withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 1990; 65:878-84.
10. Klimo P, Connors J M MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 1985; 102:596-602
11. Connors J M, Klimo P. MACOP-B chemotherapy for malignant lymphomas and related conditions 1987 update and additional observation. Semin Hematol 1988; 25.41-6.
12. Fisher R I, Gaynor E R, Dahlberg S, Oken M, Grogan T, Mize E, et al. Comparison of a standard regimen (CHOP) with 3 intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma N Engl J Med 1993, 328:1002-6.
13. Longo D L, De Vita V T, Duffey P L, Wesley M N, Ihde D C, Hubbard S M, et al. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: Results of a prospective randomized trial. J Clin Oncol 1991; 9:25-38.
14. Salles G, Shipp M A, Coiffier B Chemotherapy of non-Hodgkin's aggressive lymphoma. Semin Hematol 1994; 31:46-69.
15. Coiffier B, Bryon P A, Berger F, Archimband E, French M, Extra J-M Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80) J Clin Oncol 1986; 4:147-53.
16. Marie J P, Ziltoun R Chemotherapy of acute myelogenous leukaemia. Clin Haematol 1991, 4:97-100.
17. Foon K A, Gale R P. Therapy of acute myelogenous leukaemia. Blood Rev 1992; 6:15-25.
18. McCanley D L Therapy of adult acute leukaemia. Clin Pharm 1992, 11 767-72.
19. Wiernik P H, Banks P L C, Case D C Jr, Arlin Z A, Periman P O, Todd M B, et al. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukaemia. Blood 1992, 79 313-9.
20. Ohtsu T, Sai T, Oka M, Sugai Y, Tobinai K. Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with haematological malignancies. Jpn J Clin Oncol 1991; 21.360-5
21. Lok ASF, Lai C L Acute exacerbation in Chinese patients with chronic hepatitis B virus (HBV) infection. J Hepatol 1990, 10:29-34.
22. Liaw Y F, Tai D I, Chu C M, Pao C E, Chen T J. Acute exacerbation in chronic type B hepatitis Comparison between HBeAg and antibody positive patients. Hepatology 1987, 7:20-3.